Agilent Technologies presents microfluidic technology for quality enhancement of mitochondrial DNA sequencing
Agilent Technologies Inc. (NYSE: A) today announced that it will be a primary sponsor of the first international Human Identification E-Symposium (HumID), April 14, 2005. Mark Jensen, Ph.D., senior application chemist in Agilent’s Life Sciences and Chemical Analysis group, will speak at the symposium about how Agilent’s lab-on-a-chip technology is currently being used to enhance the quality of mitochondrial DNA (mtDNA) sequencing.
Mitochondrial DNA analysis is a primary technique for genetic typing of small or highly degraded samples. It is used for victim identification, disaster recovery and forensic DNA profiling. The technique is also used by the U.S. military for identification of remains discovered in the field.
HumID, sponsored by The Forensic Institute, will bring together experts from the scientific, law enforcement and legal communities to examine the latest processes, standards and technologies in the field of human identification and their application in the court of law. Invited speakers will include representatives from the International Association for Identification, the Federal Bureau of Investigation and the Human Identity DNA Technologies Group at the National Institute of Standards and Technology.
Jensen’s presentation, entitled “Quality Control for Mitochondrial DNA Sequencing,” is scheduled for 1:15 p.m. (ET). Registration for the e-symposium is free. More information is available at www.humid.e-symposium.com .
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company’s 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com .
